market share

General Motors becomes second-largest U.S. EV seller with strong growth, but Tesla's valuation rests on energy storage, robotaxis, and humanoid robots beyond vehicle sales.

DraftKings poised to benefit from tightening regulation of prediction markets and sector consolidation favoring established, compliant operators.

Wayfair stock retreated 35% to $78 after surging 500% on earnings strength and tariff relief expectations, but GAAP losses triggered selloff despite analyst 33% upside target.

Broadcom and Marvell capitalize on custom AI chip demand. Broadcom leads with 60% market share and 106% AI growth; Marvell offers better valuation with doubling custom processor revenue.

Eli Lilly dominates weight loss drugs with 60% U.S. market share and triple-digit growth, while Viking Therapeutics advances competitive VK2735. Lilly's 8% YTD decline and 28x forward earnings may offer value.

$KRAT surges 20% after Q4 earnings beat: $115.6M sales (+13.7% YoY), $7.2M net income (+22.8%), eco-friendly products hit 37.3% of revenue.

Apple launches $599 MacBook Neo and iPhone 17e, absorbing chip costs to gain market share in contracting markets while competitors cannot match the pricing.

Walmart offers dividend investors growth through 24% e-commerce expansion and 37% ad growth, backed by 53 years of consecutive increases and a conservative 34% payout ratio.

$NVDA dominates AI chip market with 90% share, 73% revenue growth, and $500B backlog through 2026. Trading at attractive 22x forward P/E with 43% analyst upside target.

BYD announced Blade Battery 2.0 with 5-minute fast charging to 70%, potentially disrupting Tesla's battery advantage in competitive markets.

U.S. EV registrations fell 0.4% in 2025, marking the first decline in ten years. December plunged 48% after federal tax credits expired, though Tesla maintains dominance.

TSMC stock surged 107% in one year, driven by 36% projected 2025 revenue growth and 90% market share in advanced AI chips. At 24.7x forward earnings, analysts view it as a reasonable long-term buy despite its $1.8T valuation.

Tesla's Model Y outperformed broader EV market decline in December, with registrations down just 24% versus 48% EV market decline, retaining top-selling EV position.

AI infrastructure demand drives memory chip prices up 17% and PC shipments down 10.4% in 2026, with Apple gaining share via $599 MacBook while HP faces margin pressure.

Novo Nordisk leads GLP-1 market but faces Eli Lilly competition; Amgen's MariTide offers differentiated approach with less portfolio risk.

Amazon's $200B AI infrastructure commitment positions Nvidia to benefit significantly from its deep AWS integration and technological advantage in the hyperscale AI market.

TransMedics surges 104% on organ transplant dominance and 32% growth, but 56x forward earnings premium and 25% short interest raise sustainability questions for 2026.

Apple maintains $599 entry-level pricing for iPhone 17e with doubled storage, leveraging supply chain strength to compete in price-sensitive markets, particularly China.

Shopify stock falls 25% despite 31% revenue growth to $3.7B, as valuation concerns outweigh operational strength. Company maintains 14% U.S. e-commerce share.

Sturm Ruger ($RGR) reported Q4 2025 sales of $151M, up 3.6% YoY, but swung to a $0.27 loss per share. New products drove growth.